Safety, tolerability, pharmacokinetics and pharmacodynamics of an anti- oncostatin M monoclonal antibody in rheumatoid arthritis: results from phase II randomized, placebo-controlled trials

Title
Safety, tolerability, pharmacokinetics and pharmacodynamics of an anti- oncostatin M monoclonal antibody in rheumatoid arthritis: results from phase II randomized, placebo-controlled trials
Authors
Keywords
Rheumatoid Arthritis, Active Rheumatoid Arthritis, Swell Joint Count, DAS28 Score, EULAR Response Criterion
Journal
ARTHRITIS RESEARCH & THERAPY
Volume 15, Issue 5, Pages R132
Publisher
Springer Nature
Online
2013-09-24
DOI
10.1186/ar4312

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started